Pasteurised Donor Human Milk Supplementation for Term Babies

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

1,444

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

December 31, 2028

Conditions
Neonatal HypoglycemiaMetabolic ComplicationCows Milk AllergyHospital Length of StayNeonatal Intensive Care UnitBreastfeedingMental Health Issue
Interventions
DIETARY_SUPPLEMENT

Standard care Cow's milk based formula

Standard hospital care would be given as as per local unit policy at the site.

DIETARY_SUPPLEMENT

Dietary Supplement: PDHM Pasteurised Donor Human Milk

PDHM will be given to infants randomised to the intervention group

Trial Locations (4)

4010

Royal Brisbane and Womens Hospital (QLD), Brisbane

4101

Greenslope Hospital (QLD), Brisbane

Unknown

Frances Perry House (VIC), Melbourne

Royal Womens Hospital (VIC), Melbourne

Sponsors
All Listed Sponsors
collaborator

Murdoch Childrens Research Institute

OTHER

collaborator

La Trobe University

OTHER

collaborator

University of Melbourne

OTHER

collaborator

South Australian Health and Medical Research Institute

OTHER

collaborator

Australian Red Cross Lifeblood

UNKNOWN

collaborator

Ramsay Hospital Research Foundation

UNKNOWN

collaborator

Monash University

OTHER

collaborator

The Royal Women Hospital

UNKNOWN

collaborator

Greenslopes Private Hospital

UNKNOWN

collaborator

Frances Perry House

UNKNOWN

lead

The University of Queensland

OTHER

NCT06993103 - Pasteurised Donor Human Milk Supplementation for Term Babies | Biotech Hunter | Biotech Hunter